FDA inspection
Gregory Reaman H. Clinical Investigator: FDA inspection ending Feb 16, 2000
FDA inspection 15084 · Voluntary Action Indicated (VAI) · Washington, DC
Key facts
| Inspection ID | 15084 |
|---|---|
| Firm | Gregory Reaman H. Clinical Investigator |
| FEI number | 3002944209 |
| Address | 111 Michigan Ave Nw |
| City | Washington |
| State | DC |
| ZIP | 20010-2978 |
| Fiscal year | 2000 |
| Inspection end date | Feb 16, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data